C.STIM

In this page

IPL C.STIM®, Designed for Superior Results
Treat the root causes of Dry Eye Disease
C.STIM® technology at the core of performance
Media Library
Take full advantage with a wide range of accessories
Testimonials
How to include the C.STIM® IPL in your therapeutic arsenal?
Case Studies
Want to know more?

C.STIM®, IPL SYSTEM
FOR DRY EYE TREATMENT

IPL (Intense Pulsed Light) C.STIM® technology is a premium, safe and efficient IPL system dedicated to treat the root causes of dry eye disease. This revolutionary IPL, specifically dedicated to Ophthalmic Uses, integrates patented homogeneous light and unique pulse train to offer the best combination of clinical efficacy and patient comfort.

*Not FDA approved

Key Features

Comprehensive treatment of dry eye causes: Meibomian Gland Dysfunction (MGD), chalazion, blepharitis & inflammation, Demodex, and neuropathic pain.
Dedicated optical tips for sensitive areas: Round and banana-shaped tips designed for safe, precise treatment of peri orbital and delicate zones.
Advanced software with optimized protocols: Pre-set parameters for dry eye treatment tailored to patient phototype, with open access to custom settings for additional protocols.
Safe and efficient for most skin types: Unique handpiece with optical tip integrating Stim-ULI™ technology, 5 regulated pulses, optimized light spectrum, and integrated water cooling ensure safety and effectiveness.

IPL C.STIM®, Designed for Superior Results

C.tips™: Single, Versatile Handpiece with Two Specialized Tips

Treats All Areas: Large, small, and delicate zones with precision
Easy Workflow: Two quick-attach tips - no need to change the handpiece
Round-Shaped Tip – 6 mm diameter [22,23,24,27,28]: Ideal for precise treatment of small, sensitive areas
Banana-Shaped Tip – 30 x 5 mm [22,23,24,27,28]: Designed for peri-orbital (eye contour) treatment unique on the market

Defined for Safety and Efficacy by phototype

Pre-set dry eye protocols developed with Dr. Rolando Toyos (USA)
Ensures consistent results and patient comfort across all skin types
Simplifies workflow for fast, easy sessions

Flexibility for Advanced Users

Customize fluence, pulse duration, interval time, and number of pulses
Perfect complement for practitioners applying other validated or specialized protocols

Treat the root causes
of Dry Eye Disease

C.STIM® treats dry eye disease at its source, not just its symptoms. By stimulating natural gland activity, it improves tear production and meibomian gland function while restoring tear film quality. Controlled thermal energy optimizes meibum expression, reduces inflammation, and helps eliminate Demodex.

Clinical results include: Improved tear film quality [14,15,21,25], better meibum quality and expression [16,17,25,27,28], reduction in patient symptoms [17,25], neuropathic pain relief [18,26], reduced inflammatory markers (cytokines) in tears [19,20,25].

The outcome: long-term comfort and a better quality of life for dry eye patients.

C.STIM® technology at the core of performance

Patented Technology: Stim-ULI™ (Uniform Light Intensity)

Safe and effective treatment with Stim-ULI™

Patented optical handpiece for uniform energy delivery
Eliminates temperature peaks for superior comfort and safety
No burn risk, even on darker skin types

Unique Pulse Train – 5 Pulses for Ultimate Safety & Efficacy

Better results, no side effects, comfortable

Ensures a controlled and progressive temperature increase for optimal therapeutic outcomes
Preserves skin integrity, even in delicate areas such as the peri-orbital region, while respecting the Thermal Relaxation Time (TRT)
Enhanced safety across all major skin types

Optimised handpiece

Integrated Water-Based Cooling System for Optimal Efficacy

Garanties flash lamp performance and longevity
All the sessions without compromise in efficacy
Delivers consistent energy from the first to the last shot
Ensures optimal patient comfort

Single, Versatile Handpiece with Two Specialized Tips

Treats All Areas: Large, small, and delicate zones with precision
Easy Workflow: Two quick-attach tips - no need to change the handpiece

Treatment on the majority of skin types

Safe and effective treatment for phototypes 1 to 5

Light spectrum of 610 nm to 1 200 nm is less absorbed by melanin
Energy controlled by pulse train, limiting increase in tissue temperature
Stim-ULI™ technology for a perfectly homogeneous energy distribution

Media Library

Access to all our clinical data

Take full advantage
with a wide range of accessories

Patient protective intraocular scleral shell

Testimonials

Dr Wojciech Adamski Poznań, Polska

C.STIM is a small revolution in the treatment of patients with dry eye disease associated with meibomian gland dysfunction. It allows a painless, quick, and most importantly, effective improvement of the functioning of the eyelid margins and significantly improves the patients' quality of life. After a series of sessions, patients report an improvement in the quality of life and I am very pleased to use dedicated ophthalmic devices using the IPL technology proven in medicine.

Dr Pieter Gouws Spire Sussex Hospital, UK

I have had excellent feedback from patient whom I have treated with the IPL device from Quantel Medical. It is important to manage expectations and I tell my patients to expect a noticeable improvement after 3 treatments. I am recommending 4 treatments for all cases and the typical response is an improvement in symptoms which last longer and longer after each treatment. Re-treatment with 1 session is often requested at about 1 year after the first treatment. I highly recommend this IPL for it’s ease of use and excellent training and backup provided by the suppliers.

Dr Serge Doan Bichat Hospital and Rothschild Fondation, Paris, France

I use the C.STIM IPL mainly for meibomian dysfunctions. When there is inflammation or demodex of the eyelids, I use IPL directly on the eyelids with metal palpebral shells, a protocol that studies have shown works better than periocular flashes. Patients with neuropathic pain also experience improvement after IPL sessions.

Marie-Caroline Trone Saint-Etienne, France

We have been using Quantel Medical IPL devices for several years, first LACRYSTIM and more recently C.STIM.
It is quite natural that these IPL devices have found their place in our daily practice within our consultation dedicated to dry eyes. The number of patients treated increases every year.
C.STIM is very easy to use and does not require any consumables. A session lasts only a few minutes and is perfectly painless.
The different doctors of the department have quickly adopted it, as well as the patients!

Dra. Adriana Abreu Di Luigi "El Viñedo" Ophthalmology Clinic (Venezuela)

It has truly been a before and after in the management of patients with dry eye disease, hyper evaporative, meibomitis, blepharitis, meibomian gland dysfunction and other ocular surface diseases. It is really satisfying for me as well as for the patients themselves to see the results after the treatment, in terms of improvement of their quality of life, tear film quality and visual quality.

Dr Shahin Fatima Amman, Jordan

C.DIAG and C.STIM have significantly enhanced the management of dry eye disease in my practice. This is the first integrated Dry Eye Suite of its kind in Jordan, enabling precise diagnosis and personalized, effective treatment. Since implementing this technology, I have observed improved clinical outcomes, increased patient satisfaction, and a more efficient clinical workflow. It represents a valuable advancement for modern dry eye care.

How to include the C.STIM® IPL
in your therapeutic arsenal?

IPL is now part of the therapeutic arsenal for dry eye.
Review the case study below to learn how it can be used to complement other dry eye treatments.

KLINISKA FALL AV VÅRA EXPERTER

Eftersom patientvård står i fokus för vårt intresse är det viktigt att samla erfarenheter från läkare som använder våra produkter.

Tillgång till alla våra kliniska fall

Want to know more?

How to communicate with dry eye patients?

To help you develop your dry eye business, Quantel Medical has developed a complete kit of communication tools dedicated to patients, both in paper and digital versions.

We have created this kit is the result of a simple fact that dry eye is a new pathology that still too little known, for which patients need information.

They need dedicated materials to give them a clear understanding of the pathology and its causes, symptoms, diagnosis and treatment options.

For you, as healthcare professionals, educational materials are also important to highlight this speciality when patients arrive in your waiting room and also to help you recruit new patients.

Läs mer

WANT TO DEMO C.STIM®?

Lumibird Medical participates in many events throughout the year.

Find in our Events section the next congresses in which we will participate and come, visit us on our booth to test our products!

Läs mer

Intense Pulsed Light Dry Eye Rel...

24/03/2025

Intense Pulsed Light (IPL) therapy represents a breakthrough treatment for chronic dry eye disease. This procedure uses sp...

What are the principles of inten...

15/03/2024

IPL technology has been used in dermatology since 1994 to treat of various pathologies, including skin rosacea, acne, vasc...

How to organise your dry eye con...

15/03/2024

In recent years, more and more patients have been complaining of the same symptoms: itchy, scratchy eyes and gritty feelin...

Model still available in some countries according to local registration: LacryStim
For further information, please contact us.

Bibliography :

1. Parasympathetic Innervation of the Meibomian Glands in Rats – Mark S. LeDoux et al. – Investigative Ophthalmology & Visual Science, October 2001, Vol. 42, No. 11.
2. Characterization of the innervation of the meibomian glands in humans, rats and mice – Bründl, M. et al. Annals of Anatomy (2021), Vol. 233.
3. Neurotransmitter Influence on Human Meibomian Gland Epithelial Cells – Wendy R. Kam and David A. Sullivan – Investigative Ophthalmology & Visual Science, November 2011, Vol. 52, No. 12.
4. The Dopaminergic Neuronal System Regulates the Inflammatory Status of Mouse Lacrimal Glands in Dry Eye Disease – Ji, Yong Woo et al. Investigative Ophthalmology & Visual Science (2021), Vol. 62.
5. TFOS DEWS II Pathophysiology Report – Anthony J. Bron, et al. – The Ocular Surface, 2017, p 441 to 515.
6. The neurobiology of the meibomian glands – Cox SM, Nichols JJ – Ocular Surface, July 2014.
7. Multicenter Study of Intense Pulsed Light Therapy for Patients with Refractory Meibomian Gland Dysfunction – Reiko Arita, et al. – Cornea Volume 37, Number 12, December 2018.
8. Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory Condition – Yu Ri Woo, et al. International Journal of Molecular Sciences, September 2016.
9. Rosacea: Epidemiology, pathogenesis, and treatment – Barbara M. Rainer et al. – DERMATO-ENDOCRINOLOGY 2018, VOL. 9, NO. 1, e1361574 (10 pages).
10. Treatment of ocular rosacea – Edward Wladis et al. – Survey of Ophthalmology (2018), Vol. 63.
11. Improved telangiectasia and reduced recurrence rate of rosacea after treatment with 540 nm-wavelength intense pulsed light: A prospective randomized controlled trial with a 2-year follow-up – Luo, Y. et al. – Experimental and Therapeutic Medicine (2020), Vol. 19.
12. Therapeutic Effect of Intense Pulsed Light on Ocular Demodicosis – Zhang, X., et al. – Current Eye Research 2019, Vol. 3.
13. Intense Pulsed Light Therapy for Patients with Meibomian Gland Dysfunction and Ocular Demodex Infestation – Cheng et al. – Current Medical Sciences (2019), Vol. 39.
14. Long-term effects of intense pulsed light treatment on the ocular surface in patients with rosacea-associated meibomian gland dysfunction – Seo Kyoung Yul et al. – Contact Lens and Anterior Eye (2018), Vol. 41.
15. TFOS DEWS III Management and Therapy Report - Lyndon Jones et al. – American Journal of Ophthalmology, May 2025.
16. Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction – Vigo, L. et al. – Journal of Visualized Experiment (2019), N°146.
17. Meibum Expressibility Improvement as a Therapeutic Target of Intense Pulsed Light Treatment in Meibomian Gland Dysfunction and Its Association with Tear Inflammatory Cytokines – Choi, M. et al. – Scientific Reports (2019), Vol. 9.
18. TFOS DEWS II Pain and Sensation Report – Belmonte Carlos, et al. – The Ocular Surface (2017), Vol. 15.
19. Analysis of Cytokine Levels in Tears and Clinical Correlations After Intense Pulsed Light Treating Meibomian Gland Dysfunction – LIU, R et al. – American Journal of Ophthalmology (2017).
20. Effect of inflammation on lacrimal gland function – Driss Zoukhri – Experimental Eye Research, May 2006; 82(5): 885–898.
21. Aqueous deficiency is a contributor to evaporation-related dry eye disease – Charles W. McMonnies – Eye and Vision (2020) 7:6.
22. Efficacy and safety of intense pulsed light of upper and lower eyelids in Meibomian gland dysfunction: A prospective multicentric study - Benítez-del-Castillo JM et al., Eur J Ophthalmol. 2023.
23. Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; safety and efficacy in a randomized controlled study. Toyos R, McGill W, Briscoe D. - Photobiomodul Photomed Laser Surg. 2018;36(5):241-250.
24. Intense pulsed light treatment of the upper and lower eyelids in patients with moderate-to-severe meibomian gland dysfunction. Arita R, Fukuoka S, Morishige N. J Clin Med. 2022;11(12):3581.
25. Efficacy and safety of intense pulsed light delivered by the C.STIM® for treatment of Meibomian gland dysfunction - R. Auger, M.C. Trone, E. Chhuy, S. Poinard, G. Thuret, P. Gain – Journal Français d’Ophtalmologie, May 2024, Vol. 47, Issue 5.
26. Effects of Intense Pulsed Light on Presumed Neuropathic Pain Associated with Meibomian Gland Dysfunction: A Before-After Study – G. Hoarau, A.L. Best, S. Zina-Meziou , M. Benali-Abdallah, M. Loukil, Magalie Bouvet , E. Barreau, A. Rousseau, M. Labetoulle - Journal of Ocular Pharmacology and Therapeutics, January 2025, Vol. 41, No. 1.
27. Therapeutic Efficacy and Safety of Intense Pulsed Light for Refractive Multiple Recurrent Chalazia – R. Arita and S. Fukuoka - J. Clin. Med. 2022, 11(18), 5338.
28. Novel treatment of chalazion using light‑guided‑tip intense pulsed light – Y. Zhu, H. Zhao, X. Huang, L. Lin, Y. Huo, Z. Qin, J. Lu & X. Jin - Scientific Reports (2023) 13:12393.

Download brochure

The information collected through this form is recorded and transmitted to the relevant LUMIBIRD MEDICAL departments and enables us to send you any reply to a request via the contact form. The legal basis for the processing is consent. The data collected are kept for 3 years in digital format and are only transmitted to LUMIBIRD MEDICAL’s internal departments as well as to our distributors and subsidiaries. You have a right to access, rectify, contest, limit the processing of and erase data. For more information on the use of your data and your rights resulting from the amended French Data Protection Act and the GDPR, please consult our data protection policy or contact our Data Protection Officer at privacy@lumibird.com.

I agree to my personal data being used by LUMIBIRD MEDICAL to send me marketing information about LUMIBIRD MEDIACL's new products, events or offers (mailings)

For more informations on how Lumibird Medical uses your data, please see our Terms and conditions.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

C.STIM®, IPL SYSTEM FOR DRY EYE TREATMENT